Skip to main content

Table 3 Events of toxicity during chemo- and radiochemotherapy (* = phase I study)

From: Sequential (gemcitabine/vinorelbine) and concurrent (gemcitabine) radiochemotherapy with FDG-PET-based target volume definition in locally advanced non-small cell lung cancer: first results of a phase I/II study

   Esophageal Pulmonary Hematologic
   G1 G2 G3 G1 G2 G3 G1 G2 G3
Gemcitabine (mg/m2) No. 3 19 7 18 6 5 12 9 1
300* 3 1 2 0 1 2 0 1 1 0
400* 3 1 2 0 1 2 0 1 2 0
500* 4 0 4 0 4 0 0 0 1 0
500 19 1 11 7 12 2 5 10 5 1